HoldingsChannel.com
Eyenovia insider buying image
The table below summarizes the most recent Eyenovia insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Eyenovia insider buys are important for investors to follow.
DateInsiderPriceAmount
3-28-2024
Insider Buy
Stuart M. Grant
$0.98
CAGR »
$98,000.00
100,000 shares
3-19-2024
Insider Buy
Stuart M. Grant
$1.23
CAGR »
$61,500.00
50,000 shares
3-8-2024
Insider Buy
Stuart M. Grant
$1.58
CAGR »
$16,911.43
10,717 shares
12-4-2023
Insider Buy
Michael M. Rowe
Chief Executive Officer
$1.36
CAGR »
$6,650.40
4,890 shares
9-29-2023
Insider Buy
Ellen R. Strahlman
Director
$1.68
CAGR »
$8,097.60
4,820 shares
8-17-2023
Insider Buy
Stuart M. Grant
$1.89
CAGR »
$141,915.00
75,000 shares
5-31-2023
Insider Buy
John P. Gandolfo
Chief Financial Officer
$2.79
CAGR »
$5,580.00
2,000 shares
5-26-2023
Insider Buy
Bren Kern
Chief Operating Officer
$2.73
CAGR »
$6,825.00
2,500 shares
5-26-2023
Insider Buy
Charles E. Mather IV
Director
$2.49
CAGR »
$7,469.70
3,000 shares
5-25-2023
Insider Buy
Stuart M. Grant
$2.65
CAGR »
$233,854.55
88,247 shares
5-23-2023
Insider Buy
Ellen R. Strahlman
Director
$3.10
CAGR »
$30,976.00
10,000 shares
5-15-2023
Insider Buy
Charles E. Mather IV
Director
$3.39
CAGR »
$13,560.00
4,000 shares
12-30-2022
Insider Buy
Michael M. Rowe
CHIEF EXECUTIVE OFFICER
$1.54
CAGR »
$15,400.00
10,000 shares
12-30-2022
Insider Buy
Stuart M. Grant
$1.50
CAGR »
$32,629.50
21,753 shares
8-31-2022
Insider Buy
Ellen R. Strahlman
$1.61
CAGR »
$34,445.69
21,361 shares
6-21-2022
Insider Buy
Stuart M. Grant
$1.65
CAGR »
$165,000.00
100,000 shares
5-19-2022
Insider Buy
Kenneth B. Lee Jr.
$2.20
CAGR »
$22,000.00
10,000 shares
5-11-2022
Insider Buy
Stuart M. Grant
$1.97
CAGR »
$147,750.00
75,000 shares
4-22-2022
Insider Buy
Stuart M. Grant
$2.58
CAGR »
$151,492.00
58,800 shares
3-31-2022
Insider Buy
Charles E. Mather IV
$3.12
CAGR »
$12,460.00
4,000 shares
2-22-2022
Insider Buy
Stuart M. Grant
$2.77
CAGR »
$144,000.00
52,000 shares
2-7-2022
Insider Buy
Stuart M. Grant
$2.97
CAGR »
$107,009.10
36,030 shares
12-15-2021
Insider Buy
Stuart M. Grant
$3.45
CAGR »
$345,000.00
100,000 shares
11-16-2021
Insider Buy
Stuart M. Grant
$3.61
CAGR »
$360,750.00
100,000 shares
10-29-2021
Insider Buy
Stuart M. Grant
$3.75
CAGR »
$58,139.75
15,505 shares
11-1-2021
Insider Buy
Charles E. Mather IV
$3.83
CAGR »
$15,314.40
4,000 shares
10-27-2021
Insider Buy
Michael M. Rowe
CHIEF OPERATING OFFICER
$4.14
CAGR »
$4,968.00
1,200 shares
10-26-2021
Insider Buy
Stuart M. Grant
$4.00
CAGR »
$535,224.00
133,806 shares
9-13-2021
Insider Buy
Michael M. Rowe
Chief Operating Officer
$4.40
CAGR »
$6,600.00
1,500 shares
8-19-2021
Insider Buy
Stuart M. Grant
$3.98
CAGR »
$198,984.04
50,000 shares
8-18-2021
Insider Buy
Stuart M. Grant
$4.00
CAGR »
$97,310.92
24,343 shares
5-28-2021
Insider Buy
Charles E. Mather IV
Director
$4.76
CAGR »
$14,268.30
3,000 shares
5-27-2021
Insider Buy
Michael M. Rowe
Chief Operating Officer
$4.71
CAGR »
$6,594.00
1,400 shares
4-20-2021
Insider Buy
Stuart M. Grant
$4.84
CAGR »
$293,663.12
60,692 shares
11-19-2020
Insider Buy
John P. Gandolfo
Chief Financial Officer
$3.40
CAGR »
$13,600.00
4,000 shares
10-12-2020
Insider Buy
Stuart M. Grant
$3.55
CAGR »
$355,000.00
100,000 shares
9-24-2020
Insider Buy
Stuart M. Grant
$2.99
CAGR »
$224,500.00
75,000 shares
8-20-2020
Insider Buy
Stuart M. Grant
$2.71
CAGR »
$2,128,233.96
784,620 shares
3-24-2020
Insider Buy
Tsontcho Ianchulev
Chief Executive Officer
$2.27
CAGR »
$187,118.37
82,431 shares
3-24-2020
Insider Buy
Ernest Mario
Director
$2.27
CAGR »
$187,118.37
82,431 shares
3-23-2020
Insider Buy
Stuart M. Grant
$2.06
CAGR »
$1,858,867.92
903,240 shares
9-30-2019
Insider Buy
Michael M. Rowe
Vice President, Commercial
$3.84
CAGR »
$384.00
100 shares
11-13-2019
Insider Buy
Stuart M. Grant
$3.03
CAGR »
$397,172.45
131,017 shares
7-11-2019
Insider Buy
Tsontcho Ianchulev
Chief Executive Officer
$2.78
CAGR »
$650,000.14
233,813 shares
7-11-2019
Insider Buy
Curt H. Labelle
Director
$2.78
CAGR »
$49,998.30
17,985 shares
7-11-2019
Insider Buy
Ernest Mario
Director
$2.78
CAGR »
$99,999.38
35,971 shares
1-29-2018
Insider Buy
Ernest Mario
Director
$10.00
CAGR »
$900,000.00
90,000 shares
9-25-2018
Insider Buy
Michael M. Rowe
Vice President of Marketing
$4.22
CAGR »
$3,380.00
800 shares
1-29-2018
Insider Buy
Pharmaceutical CO., LTD. Senju
>10% Owner
$10.00
CAGR »
$1,000,000.00
100,000 shares
1-29-2018
Insider Buy
Shuhei Yoshida
Director and >10% Owner
$10.00
CAGR »
$1,000,000.00
100,000 shares
1-29-2018
Insider Buy
Curt H. Labelle
Director and >10% Owner
$10.00
CAGR »
$100,000.00
10,000 shares
1-29-2018
Insider Buy
Fredric N. Eshelman
Director and >10% Owner
$10.00
CAGR »
$3,350,000.00
335,000 shares
1-29-2018
Insider Buy
Tsontcho Ianchulev
Chief Executive Officer
$10.00
CAGR »
$100,000.00
10,000 shares

Also See: Institutional Holders of EYEN
Also See: SEC filings

EYEN Performance Since Insider Purchase
Below we present the annualized performance delivered by Eyenovia stock since 3-28-2024 (the date of the most recent insider purchase). The performance of the investment from the time Eyenovia insider buying occurred is the ultimate test of whether insiders were right about EYEN being a good buy.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/01/2024
End date: 05/02/2024
Start price/share: $0.98
End price/share: $0.94
Dividends collected/share: $0.00
Total return: -4.78%
Annualized Gain: -56.24%
Starting investment: $10,000.00
Ending investment: $9,522.00
Years: 0.08

Eyenovia Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Eyenovia insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding EYEN

Quotes delayed 20 minutes

Email EnvelopeFree EYEN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Other companies seeing insider buying close in time to when the Eyenovia Insider Buying occurred are:

Reddit Inc Class A Insider Buying
Herbalife Ltd (New) Insider Buying
ARS Pharmaceuticals Insider Buying
Summit Therapeutics Insider Buying
Mirum Pharmaceuticals Insider Buying
Epsilon Energy Insider Buying
Bridgford Foods Insider Buying
Sagimet Biosciences Insider Buying
Advance Auto Parts Insider Buying
Cartesian Therapeutics Insider Buying

Eyenovia Insider Buying | www.HoldingsChannel.com

Copyright © 2013 - 2024, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.